Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases - Related Studies

Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases (Prometheus)

This study has been withdrawn prior to enrollment.

( Boston Scientific has decided to close the Study. )

Study NCT00510627 Information provided by Boston Scientific Corporation

First Received on July 31, 2007. Last Updated on December 20, 2007 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Colorectal Neoplasms
Liver Neoplasms
Neoplasms

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

Antibodies, Monoclonal
Cetuximab

More general drug interventions related to this trial

Sponsors listed in this trial